Correspondence
Other versions:
- Article InfoArticle Info
- CiteCite
- MetricsMetrics
- CommentComment
- RelatedRelated
- DataData
- CitedCited
European Science Editing 49: e112023
doi:
10.3897/ese.2023.e112023
Published:
06 Nov 2023
This article is part of:
Authors
Piero Pollesello
- Corresponding author
Orion Pharma, Espoo, Finland
University of Debrecen, Debrecen, Hungary
Academic editor

Rijeka University,Faculty of Health Studies, Rijeka, Croatia
Conflict of interest
The authors have declared that no competing interests exist.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Subscribe to email alerts for current Article's categories